Partnerships Built for Progress.
Specialized technologies. Shared expertise. More ways to advance your cell therapy program.
Cell therapy development depends on capabilities that span organizations and disciplines. Connecting them takes scientific expertise, operational planning, and a clear understanding of what your program needs next.
Made Scientific works with technology providers, therapy developers, and academic institutions to bring new tools into manufacturing, advance client programs, and develop the people behind GMP operations. Each partnership addresses a specific need, from starting materials and process automation to clinical supply and workforce training.
Technology and supply partnerships
Technologies, materials, and equipment that expand what’s possible in cell therapy development and manufacturing.
RoosterBio
MSC and extracellular vesicle platforms integrated into Made Scientific’s development and manufacturing services, from process development through commercial supply.
Pluristyx
Clinical-grade iPSC lines and derivative cell types paired with Made Scientific’s process development and manufacturing expertise to support progression toward the clinic.
Syenex
RapidCell™ vector technology powers MadeFast™, Made Scientific’s single-step CAR-T platform designed to reduce manufacturing time, cost, and complexity.
Streamline Bio
Exclusive Early Adopter Program for the co-development, integration, and validation of AI-driven robotic automation for cell therapy manufacturing.
CARR Biosystems
UniFuge® single-use centrifugation integrated across Made Scientific's Princeton and East Norriton facilities for scalable MSC manufacturing.
Telos Biotech
Evaluating TELOVANCE™, a telomerase-based technology, for potential use in CAR T-cell, NK-cell, and hematopoietic stem/progenitor cell workflows.
Client programs and partnerships
Supporting therapy developers with the process development, manufacturing, and technical expertise their programs need to advance.
NurExone Biologic
A binding MOU covering planned GMP manufacturing and aseptic fill-finish for NurExone’s bone marrow-derived exosomes.
Columbia University
Process development and GMP manufacturing for NOVAKnee, a living biologic total knee replacement.
Regenicin
Manufacturing and IND support for NovaDerm, an autologous skin substitute being developed for burns and wounds.
Cytora Therapeutics and Zeo ScientifiX
Exclusive U.S. manufacturing for Cytora's allogeneic oral mucosal stem cell therapy for diabetic foot ulcers, with Zeo ScientifiX as the exclusive U.S. commercial partner.
Cellergy Therapeutics
Process scale-up and GMP production for CLG-001, an investigational mitochondrial transplantation therapy.
Hemogenyx Pharmaceuticals
Technology transfer and manufacturing for HG-CT-1, an autologous CAR-T therapy for acute myeloid leukemia.
Sentinel BioTherapeutics
Cell banking and clinical manufacturing for SENT-001, an allogeneic encapsulated therapy for solid tumors.
Academic and workforce partnerships
Working with academic institutions to connect education with the practical demands of cell therapy manufacturing.
New Jersey Institute of Technology
Co-developed graduate electives that connect bioprocessing education with practical cell therapy manufacturing experience.
Ways to partner
Dedicated Capacity and Embedded Teams
Align Made Scientific personnel and manufacturing capacity with your program’s requirements and schedule.
Best suited to programs that need continuity across development, analytical testing, and GMP manufacturing.
Hybrid Client-in-Plant
Run your program with your own staff inside Made Scientific’s GMP facilities through a hybrid client-in-plant model.
Best suited to mid- to late-stage programs that want their own team operating inside our facilities.
Technology and Supply Partnerships
Work with Made Scientific to evaluate and integrate technologies, materials, and equipment into cell therapy workflows.
Best suited to technology and supply partners seeking to establish how their solutions perform in development and GMP manufacturing settings.
Customized Build-Outs
Plan fully customized build-outs for late-stage and commercial manufacturing, supported by GC’s long-term investment in capacity, technology, and experienced teams.
Best suited to late-stage and commercial programs aligning manufacturing with long-term strategic goals.
Why partner with Made Scientific
Planning for scale from the start
We consider manufacturing scale, analytical requirements, automation opportunities, and cost as processes develop, helping teams prepare for the demands of later-stage and commercial supply.
Partnerships shaped around your process
We assess technologies and workflows against your program’s technical requirements, regulatory considerations, and commercial objectives. Those needs guide how we structure the partnership.
Scientific expertise grounded in GMP execution
Our experience spans autologous and allogeneic cell therapies, including CAR-T, CAR-NK, TILs, MSCs, and iPSC-derived products. Development and manufacturing teams work together to connect process decisions with the requirements of GMP production.
Let’s Build What Your Program Needs Next
Whether you’re advancing a therapy, developing a technology, or building manufacturing expertise, let’s explore where we can work together.